Q1 EPS Estimate for Lyell Immunopharma Boosted by Analyst
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) – Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for Lyell Immunopharma in a research note issued on Thursday, March 13th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.17) per share for the quarter, up from […]
Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) – Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for Lyell Immunopharma in a research note issued on Thursday, March 13th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.17) per share for the quarter, up from […]
